Clinical Trial Update: Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 trial results update showing safety and efficacy data for HL Tablet in patients with non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• HL Tablet

Snippet

Sponsor: Huons Co., Ltd. | Conditions: Non-alcoholic Fatty Liver Disease | Phase 2 | Status: COMPLETED